Biophytis (BPTS) Announces Proposed Common Offering and Nasdaq Listing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to Biophytis (BPTS) Announces Proposed Common Offering and Nasdaq Listing
February 3, 2021 2:00 AM EST
PARIS and CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS) (Biophytis or the Company), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces its intention to offer and sell, subject to market and other conditions, up to 12.0 million ordinary shares represented by 1.2 million American Depositary Shares (the ADSs), with each ADS representing ten ordinary shares, in the United States (the ADS Offering).
...
More
